Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aurelia Private Equity

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 4
Rounds per year 0.23
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • 3D Technology
  • Messaging
  • Music
  • Pharmaceutical
Summary

In 2000 was created Aurelia Private Equity, which is appeared as VC. The venture was found in Europe in Germany. The main department of described VC is located in the Frankfurt.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Messaging. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular portfolio startups of the fund, we may highlight MerLion Pharma, GILUPI, Combinature Biopharm.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Aurelia Private Equity, startups are often financed by Zu00fcrcher Kantonal Bank, Temasek Holdings, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are BC Brandenburg Capital, Viroad Biotechnology, Rosetta Capital. In the next rounds fund is usually obtained by Innoven Partners, Generis Capital Partners, Brandenburg Kapital.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2010. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2016. Comparing to the other companies, this Aurelia Private Equity performs on 9 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Aurelia Private Equity:
Typical Co-investors
Aurelia Private Equity is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Aurelia Private Equity:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aurus Chile, Lo Barnechea, Santiago Metropolitan Region
Blom ASA Norway, Oslo
CBG Asset Management -
Chorom Pak -
Dotc United Group China, Shanghai
ELAS Technology Investment Achim, Germany, Lower Saxony
Future Shape France, Ile-de-France, Paris
Inland TechStart Fund Spokane, United States, Washington
Tibet Qiming Music Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

GILUPI

Biotechnology
Health Care
Medical
Medical Device
$4M13 Jan 2011 Potsdam, Brandenburg, Germany

Club Cooee

3D Technology
Messaging
Music
27 Oct 2010 Germany, Rhineland-Palatinate

Biotechnology
Pharmaceutical
$7M11 Oct 2010 Central

Club Cooee

3D Technology
Messaging
Music
20 Oct 2007 Germany, Rhineland-Palatinate

Biotechnology
$5M08 May 2006 Germany, Berlin

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aurelia Private Equity?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 3M
Rounds per year 0.23
Peak activity year 2010
Lead investments 1
Follow on index 0.20
Exits 1
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

GILUPI

Biotechnology
Health Care
Medical
Medical Device
$4M13 Jan 2011 Potsdam, Brandenburg, Germany

Club Cooee

3D Technology
Messaging
Music
27 Oct 2010 Germany, Rhineland-Palatinate

Biotechnology
Pharmaceutical
$7M11 Oct 2010 Central

Club Cooee

3D Technology
Messaging
Music
20 Oct 2007 Germany, Rhineland-Palatinate

Biotechnology
$5M08 May 2006 Germany, Berlin
Crunchbase icon

Content report

The following text will be sent to our editors: